查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378470

脱髮症治疗市场：按药物类别、疾病途径、配销通路和地区

Alopecia Treatment Market, By Drug Class, By Disease Type, By Route of Administration, By Distribution Channel, By geography
出版日期: | 出版商: Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年，全球脱髮症治疗市场规模将达到96.5亿美元，预测期内（2023-2030年）年复合成长率为5.6%。

报告范围 报告详情
基准年 2022年 2023年市场规模 96.5亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 5.60% 2030年市场规模预测 141.6亿美元
图 1. 2023 年脱髮症治疗的全球市场占有率(%)（依药物类别）
脱髮治疗市场-IMG1

脱髮症是医学术语，用于描述身体正常毛髮所在区域的毛髮部分或完全脱落。这种情况会影响头皮、眉毛、睫毛、鬍鬚或身体其他毛髮生长的部位。脱髮症可以是暂时的，也可以是永久性的，由多种因素引起，包括遗传倾向、荷尔蒙变化、自体免疫疾病、医学治疗以及某些环境和心理因素。脱髮症有多种类型，每种类型都有不同的特征和根本原因。这些包括脱髮症（以斑状脱髮为特征）、雄性脱髮症（俗称雄性秃或女性型脱髮症）、毛细血管扩张性脱髮（突然、广泛的脱髮症）和牵引性脱髮症（由于反覆拉扯或拉紧头髮而引起） ）。

市场动态

市场上的主要企业都专注于内部成长策略，例如脱髮症资金筹措，预计这将在预测期内推动全球脱髮症治疗市场的成长。例如，2023 年 7 月，开发可溶性CD83（sCD83）治疗脱髮症的生物製药公司 Mallia Therapeutics GmbH 宣布已获得种子资金。该公司计划根据 2023 年 6 月在英国谢菲尔德举行的第 20 届欧洲头髮研究协会 (EHRS) 上公布的临床前和体外人体资料开发其 sCD83 候选药物。 Mallia Therapeutics GmbH 正在开发 sCD83 的双重作用模式，用于治疗荷尔蒙诱导的雄性脱髮症和自体免疫导的雄性脱髮症。此外，增加脱髮症治疗的研发活动预计将在预测期内推动全球脱髮症治疗市场的成长。例如，2022年11月，临床阶段生物技术公司Equillium, Inc.启动了EQ101的2期开放标籤研究，以评估对中重度脱髮症成人受试者的疗效和安全性。考试开始了。该试验预计将在澳洲多个临床中心招募约 30 名参与者。

本次测试的主要特点

  • 该报告对全球脱髮症治疗市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和复合年度（年复合成长率）。
  • 它还阐明了不同细分市场的潜在收益成长机会，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球脱髮症治疗市场的主要企业。
  • 本研究涵盖的主要企业包括 Stemson Therapeutics、OliX Pharmaceuticals, Inc、辉瑞 Inc、Aclaris Therapeutics, Inc、Fagron、Follicum AB、Cipla Inc、Arcutis Biotherapeutics、Dr. Reddy's Laboratories Ltd.、Himalaya Wellness Company、Stemson Therapu​​ys、Stemsgratics Company、St NV、Equillium, Inc.、礼来公司、Concert Pharmaceuticals Inc. 和Teva Pharmaceutical Industries Ltd.
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球脱髮症治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球脱髮症治疗市场的各种策略矩阵来促进他们的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 最近的趋势
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • PEST分析
  • 波特的分析

第4章全球脱髮症治疗市场-新型冠状病毒感染疾病（COVID-19）的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球脱髮症治疗市场，依药物类别，2018-2030

  • 皮质类固醇
  • 5 AR抑制剂
  • 血管扩张剂
  • 其他的

第6章全球脱髮症治疗市场，依疾病类型，2018-2030

  • 脱髮症
  • 雄性脱髮症
  • 牵引脱髮症
  • 其他的

第7章全球脱髮症治疗市场，依给药途径，2018-2030

  • 涂布
  • 口服
  • 可注射的

第8章全球脱髮症治疗市场，按配销通路，2018-2030

  • 医院药房
  • 零售药房
  • 网路药房

第9章全球脱髮症治疗市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Stemson Therapeutics .
    • OliX Pharmaceuticals
    • Pfizer Inc
    • Aclaris Therapeutics
    • Fagron,
    • Follicum AB
    • Cipla Inc.
    • Arcutis Biotherapeutics
    • Dr. Reddy's Laboratories Ltd
    • Himalaya Wellness Company
    • Cosmo Pharmaceuticals NV
    • Equillium, Inc.
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc
    • Teva Pharmaceutical Industries Ltd.
  • 分析师观点

第11章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI1847

Global alopecia treatment market is estimated to be valued at US$ 9.65 Bn in 2023, and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.65 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 14.16 Bn
Figure 1. Global Alopecia Treatment Market Share (%), By Drug Class, 2023
Alopecia Treatment Market - IMG1

Alopecia is a medical term that is used to describe the partial or complete loss of hair from areas of the body where hair is normally found. This condition can affect the scalp, eyebrows, eyelashes, beard, or any other part of the body where hair grows. Alopecia can be temporary or permanent, and can occur due to a variety of factors including genetic predisposition, hormonal changes, autoimmune disorders, medical treatments, and certain environmental or psychological factors. There are several types of alopecia, each with distinct characteristics and underlying causes. These include alopecia areata (characterized by patchy hair loss), androgenetic alopecia (commonly known as male-pattern or female-pattern baldness), telogen effluvium (sudden and widespread hair shedding), traction alopecia (caused by repeated pulling or tension on the hair), and others.

Market Dynamics

The key players in operating in the market are focusing on organic growth strategies such as fund raising for alopecia is expected to propel the global alopecia treatment market growth over the forecast period. For instance, in July 2023, Mallia Therapeutics GmbH, a biopharmaceutical company that is developing soluble CD83 (sCD83) for the treatment of hair loss, announced that it had secured its seed financing. The company plans to develop the sCD83 candidate based on preclinical and ex vivo human data, presented at the 20th meeting of the European Hair Research Society (EHRS) held in Sheffield, UK, in June 2023. sCD83 can be applied topically to reach the hair follicle, which is a big advantage as compared to systemic treatment options. Mallia Therapeutics GmbH develops the dual mode of action of sCD83 for the treatment of hormone-induced male or female pattern baldness (= androgenetic alopecia) and autoimmune mediated male or female patchy hair loss (= alopecia areata), the two most prevalent forms of hair loss. Moreover, increasing research and development activities for alopecia treatment is expected to drive global alopecia treatment market growth over the forecast period. For Instance, In November 2022, Equillium, Inc., a clinical-stage biotechnology company, announced that it had initiated a Phase 2 open-label study of EQ101 to assess efficacy and safety in adult subjects with moderate to severe alopecia areata. The study is expected to enroll approximately 30 subjects at multiple clinical sites in Australia.

Key features of the study:

  • This report provides an in-depth analysis of the global alopecia treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global alopecia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy's Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alopecia treatment market

Detailed Segmentation:

  • Global Alopecia Treatment Market, By Drug Class:
    • Corticosteroids
    • 5 AR Inhibitors
    • Vasodilators
    • Others
  • Global Alopecia Treatment Market, By Disease Type:
    • Alopecia Areata
    • Androgenic Alopecia
    • Traction Alopecia
    • Others
  • Global Alopecia Treatment Market, By Route of Administration:
    • Topical
    • Oral
    • Injectable
  • Global Alopecia Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Alopecia treatment Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Stemson Therapeutics .
    • OliX Pharmaceuticals, Inc
    • Pfizer Inc
    • Aclaris Therapeutics, Inc.
    • Fagron
    • Follicum AB
    • Cipla Inc.,
    • Arcutis Biotherapeutics
    • Dr. Reddy's Laboratories Ltd.,
    • Himalaya Wellness Company
    • Stemson Therapeutics
    • Cosmo Pharmaceuticals N.V.
    • Equillium, Inc.
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Disease Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Recent Trends
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. Global Alopecia Treatment Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Alopecia Treatment Market, By Drug Class, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • 5 AR Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Vasodilators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Alopecia Treatment Market, By Disease Type, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Alopecia Areata
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Androgenic Alopecia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Traction Alopecia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Alopecia Treatment Market, By Route of Administration, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

8. Global Alopecia Treatment Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Alopecia Treatment Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Stemson Therapeutics .
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • OliX Pharmaceuticals
    • Pfizer Inc
    • Aclaris Therapeutics
    • Fagron,
    • Follicum AB
    • Cipla Inc.
    • Arcutis Biotherapeutics
    • Dr. Reddy's Laboratories Ltd
    • Himalaya Wellness Company
    • Cosmo Pharmaceuticals N.V.
    • Equillium, Inc.
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc
    • Teva Pharmaceutical Industries Ltd.
  • Analysts' Views

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact